These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 8913452)
1. Validation and nephrotoxicity of a simplified once-daily aminoglycoside dosing schedule and guidelines for monitoring therapy. Prins JM; Weverling GJ; de Blok K; van Ketel RJ; Speelman P Antimicrob Agents Chemother; 1996 Nov; 40(11):2494-9. PubMed ID: 8913452 [TBL] [Abstract][Full Text] [Related]
2. Controlled comparison of gentamicin and tobramycin nephrotoxicity. Matzke GR; Lucarotti RL; Shapiro HS Am J Nephrol; 1983; 3(1):11-7. PubMed ID: 6340504 [TBL] [Abstract][Full Text] [Related]
3. Experience with a once-daily dosing program of aminoglycosides in critically ill patients. Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533 [TBL] [Abstract][Full Text] [Related]
4. Comparison of gentamicin and tobramycin nephrotoxicity in patients receiving individualized-pharmacokinetic dosing regimens. Pancorbo S; Compty C; Heissler J Biopharm Drug Dispos; 1982; 3(1):83-8. PubMed ID: 7082782 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic drug monitoring of tobramycin: once-daily versus twice-daily dosage schedules. Sánchez-Alcaraz A; Vargas A; Quintana MB; Rocher A; Querol JM; Poveda JL; Hermenegildo M J Clin Pharm Ther; 1998 Oct; 23(5):367-73. PubMed ID: 9875685 [TBL] [Abstract][Full Text] [Related]
6. [Serum level-adjusted dosage of once-daily aminoglycoside therapy in critical illness: results of a prospective study]. Reimann IR; Meier-Hellmann A; Pfeifer R; Traut T; Schilling A; Stein G; Reinhart K; Hoffmann A Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 May; 34(5):288-95. PubMed ID: 10372218 [TBL] [Abstract][Full Text] [Related]
7. A randomized comparison of the safety and efficacy of once-daily gentamicin or thrice-daily gentamicin in combination with ticarcillin-clavulanate. Gilbert DN; Lee BL; Dworkin RJ; Leggett JL; Chambers HF; Modin G; Täuber MG; Sande MA Am J Med; 1998 Sep; 105(3):182-91. PubMed ID: 9753020 [TBL] [Abstract][Full Text] [Related]
8. Comparison of once-daily versus pharmacokinetic dosing of aminoglycosides in elderly patients. Koo J; Tight R; Rajkumar V; Hawa Z Am J Med; 1996 Aug; 101(2):177-83. PubMed ID: 8757358 [TBL] [Abstract][Full Text] [Related]
9. Risk factors for nephrotoxicity in elderly patients receiving once-daily aminoglycosides. Raveh D; Kopyt M; Hite Y; Rudensky B; Sonnenblick M; Yinnon AM QJM; 2002 May; 95(5):291-7. PubMed ID: 11978900 [TBL] [Abstract][Full Text] [Related]
10. Comparative nephrotoxicity of gentamicin and tobramycin: pharmacokinetic and clinical studies in 201 patients. Schentag JJ; Plaut ME; Cerra FB Antimicrob Agents Chemother; 1981 May; 19(5):859-66. PubMed ID: 7294770 [TBL] [Abstract][Full Text] [Related]
11. Renal and auditory toxicity of high-dose, prolonged therapy with gentamicin and tobramycin in pseudomonas endocarditis. Tablan OC; Reyes MP; Rintelmann WF; Lerner AM J Infect Dis; 1984 Feb; 149(2):257-63. PubMed ID: 6421944 [TBL] [Abstract][Full Text] [Related]
12. Gentamicin in neonatal infection: once versus twice daily dosage. Chotigeat U; Narongsanti A; Ayudhya DP J Med Assoc Thai; 2001 Aug; 84(8):1109-15. PubMed ID: 11758844 [TBL] [Abstract][Full Text] [Related]
13. Randomized controlled trial of once- versus thrice-daily tobramycin in febrile neutropenic children undergoing stem cell transplantation. Sung L; Dupuis LL; Bliss B; Taddio A; Abdolell M; Allen U; Rolland M; Tong A; Taylor T; Doyle J J Natl Cancer Inst; 2003 Dec; 95(24):1869-77. PubMed ID: 14679156 [TBL] [Abstract][Full Text] [Related]
14. Assessment of aminoglycoside dosing and estimated glomerular filtration rate in determining gentamicin and tobramycin area under the curve and clearance. Lim AK; Mathanasenarajah G; Larmour I Intern Med J; 2015 Mar; 45(3):319-29. PubMed ID: 25581282 [TBL] [Abstract][Full Text] [Related]
15. A prospective comparative study of gentamicin- and amikacin-induced nephrotoxicity in patients with normal baseline renal function. Sweileh WM Fundam Clin Pharmacol; 2009 Aug; 23(4):515-20. PubMed ID: 19709328 [TBL] [Abstract][Full Text] [Related]
16. One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates. Rao SC; Ahmed M; Hagan R Cochrane Database Syst Rev; 2006 Jan; (1):CD005091. PubMed ID: 16437518 [TBL] [Abstract][Full Text] [Related]
17. Once-daily vs. continuous aminoglycoside dosing: efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin, and tobramycin. Powell SH; Thompson WL; Luthe MA; Stern RC; Grossniklaus DA; Bloxham DD; Groden DL; Jacobs MR; DiScenna AO; Cash HA; Klinger JD J Infect Dis; 1983 May; 147(5):918-32. PubMed ID: 6860416 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic dosing of aminoglycosides: a controlled trial. Bartal C; Danon A; Schlaeffer F; Reisenberg K; Alkan M; Smoliakov R; Sidi A; Almog Y Am J Med; 2003 Feb; 114(3):194-8. PubMed ID: 12637133 [TBL] [Abstract][Full Text] [Related]
19. Wide variation in single, daily-dose aminoglycoside pharmacokinetics in patients with burn injuries. Hoey LL; Tschida SJ; Rotschafer JC; Guay DR; Vance-Bryan K J Burn Care Rehabil; 1997; 18(2):116-24. PubMed ID: 9095420 [TBL] [Abstract][Full Text] [Related]
20. Clinical and pharmacokinetic characteristics of aminoglycoside nephrotoxicity in 201 critically ill patients. Schentag JJ; Cerra FB; Plaut ME Antimicrob Agents Chemother; 1982 May; 21(5):721-6. PubMed ID: 7103453 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]